Bioventus (BVS) Cash from Operations (2020 - 2026)

Bioventus has reported Cash from Operations for 7 years, with the latest figure at 8934000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 146.22% year-over-year to 8934000.0; the trailing twelve-month figure through Mar 2026 stood at 102938000.0 (up 304.17% YoY), and the FY2025 full-year result was 74673000.0, up 92.48% from the prior year.
• Cash from Operations for Q1 2026 stood at 8934000.0, down from 37968000.0 in the prior quarter.
• The five-year high for Cash from Operations was 37968000.0 in Q4 2025, with the low at 21019000.0 in Q2 2022.
• Historically, Cash from Operations has averaged 7559294.12 across 5 years, with a median of 8934000.0 in 2026.
• Annual changes were most pronounced in 2023 — Cash from Operations tumbled 3989.87% — and 2024, when it surged 267.85%.
• Bioventus' Cash from Operations stood at 6515000.0 in 2022, then jumped by 59.23% to 10374000.0 in 2023, then soared by 86.25% to 19322000.0 in 2024, then soared by 96.5% to 37968000.0 in 2025, then tumbled by 76.47% to 8934000.0 in 2026.
• The last three Cash from Operations figures came in at 8934000.0 (Q1 2026), 37968000.0 (Q4 2025), and 30098000.0 (Q3 2025), per Business Quant data.